News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Myelodysplastic Syndrome
October 20, 2025
GLP-1 Drugs: A New Clue in Inflammation, Blood Cancer, and Cancer Risk
Meg Monday
August 28, 2025
Advances in Genomic Testing-What you Need to Know
Charles H. Weaver, MD
June 18, 2025
Promising Results for Bexmarilimab Plus Azacitidine in High-Risk MDS
Charles H. Weaver, MD
October 25, 2023
Tibsovo for Treatment of Acute Myeloid Leukemia
Charles H. Weaver, MD
August 30, 2023
Reblozyl® Approved to Treat Anemia for Lower-Risk Myelodysplastic Syndromes
Charles H. Weaver, MD
June 17, 2021
Rusfertide-a New Option to Avoid Phlebotomy
Charles H. Weaver, MD
December 5, 2020
Magrolimab Anti-CD47 Monoclonal Antibody
Charles H. Weaver, MD
November 28, 2020
Stem Cell Transplant – Successful Treatment for Myelodysplastic Syndromes
Charles H. Weaver, MD
October 24, 2020
Overview of Myelodysplastic Syndromes
Charles H. Weaver, MD
July 22, 2020
Inqovi (cedazuridine) Treatment for Myelodysplastic Syndromes and CMML
Charles H. Weaver, MD
July 7, 2020
Dacogen™ Effective in Myelodysplastic Syndromes
Charles H. Weaver, MD
April 28, 2020
What Are The Long-Term Side Effects of Autologous Stem Cell Transplant?
Charles H. Weaver, MD
1
2
3
4
Next Page
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
